A detailed history of Larson Financial Group LLC transactions in Glaukos Corp stock. As of the latest transaction made, Larson Financial Group LLC holds 10 shares of GKOS stock, worth $880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 31 67.74%
Holding current value
$880
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$82.27 - $103.29 $1,727 - $2,169
-21 Reduced 67.74%
10 $1,000
Q1 2025

May 02, 2025

BUY
$96.6 - $161.22 $2,608 - $4,352
27 Added 675.0%
31 $3,000
Q2 2024

Aug 02, 2024

BUY
$89.48 - $118.35 $357 - $473
4 New
4 $0

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.19B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.